Convalescent plasma: possible therapy for novel coronavirus disease 2019.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research.Transfusion medicine (Oxford, England) · 2021
   Pooled it
2. Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.JMIR public health and surveillance · 2021
   Pooled it
3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.The Cochrane database of systematic reviews · 2020
   Pooled it
4. The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice.Cell reports. Medicine · 2023
   Article
5. Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review.Florence Nightingale journal of nursing · 2022
   Article
6. A Review on Effectiveness of Plasma Therapy in Severe COVID-19 Patients.Cureus · 2022
   Review
7. Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.Human vaccines & immunotherapeutics · 2022
   Review
8. Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment.Clinical nutrition open science · 2022
   Review
9. SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2022
   Article
10. Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors.Transfusion · 2021
    Article
11. Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key.Journal of translational internal medicine · 2021
    Article
12. Perplexing issues for convalescent immune plasma therapy in COVID-19.Northern clinics of Istanbul · 2021
    Review
13. The true historical origin of convalescent plasma therapy.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020
    Article
14. Drug treatment of coronavirus disease 2019 (COVID-19) in China.European journal of pharmacology · 2020
    Review
15. International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.Transfusion medicine reviews · 2020
    Review
16. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?Frontiers in microbiology · 2020
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as